VYGR: Voyager Therapeutics, Inc. Stock

by  •  • Comments Off on VYGR: Voyager Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 401.82
Enterprise Value ($M) 333.02
Book Value ($M) 236.32
Book Value / Share 4.35
Price / Book 1.70
NCAV ($M) 204.72
NCAV / Share 3.77
Price / NCAV 1.96

Profitability (mra)
Return on Invested Capital (ROIC) 0.52
Return on Assets (ROA) 0.39
Return on Equity (ROE) 0.61

Liquidity (mrq)
Quick Ratio 4.96
Current Ratio 4.96

Balance Sheet (mrq) ($M)
Current Assets 319.68
Assets 351.28
Liabilities 114.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 250.01
Operating Income 122.01
Net Income 132.33
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 77.92
Cash from Investing -141.64
Cash from Financing 33.65

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.63 24.73
02-14 13G/A Third Rock Ventures III, L.P. 0.40 -96.59
02-13 13G/A Vanguard Group Inc 5.75 29.38
01-29 13G BlackRock Inc. 6.00 179.28

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 56,390 426,918 13.21
2024-04-24 45,695 249,907 18.28
2024-04-23 56,019 172,536 32.47
2024-04-22 53,491 130,035 41.14

(click for more detail)

Similar Companies
VRTX – Vertex Pharmaceuticals Incorporated VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc. XBIT – XBiotech Inc.
XERS – Xeris Biopharma Holdings, Inc.


Financial data and stock pages provided by
Fintel.io